What is the recommended dose of Umbralisib? Does it need to be taken on an empty stomach?

Umbralisib (trade name UKONIQ) is an oral PI3Kδ and CK1ε dual kinase inhibitors are mainly used to treat relapsed or refractory marginal zone lymphoma (MZL) and follicular lymphoma (FL). According to clinical trials and drug instructions, the recommended standard dose of Albuliside is 800 mg per day, usually divided into two doses, morning and evening, 400 mg each time. This divided administration method helps maintain a stable drug concentration in the body and improves the therapeutic effect.

Regarding the taking time, the instructions for Albrix do not strictly require that it must be taken on an empty stomach. Patients can choose to take it with a meal or on an empty stomach according to their personal habits. The key is to maintain the consistency of the daily medication time to ensure the stable effect of the medicine. No matter which method you choose, you should avoid taking drugs or foods that may affect drug absorption at the same time to reduce drug interactions.

During the period when patients are taking Albulisate, they should strictly follow the doctor's instructions and the requirements of the drug instructions. They should not adjust the dosage or change the frequency of taking the medicine at will. If serious adverse reactions occur or are intolerable, you should contact your doctor in time. The doctor may adjust the dose or suspend the medication according to the specific situation to ensure medication safety.

In short, the recommended dose of Albrisid is 800mg per day, taken twice in the morning and evening. The taking time can be flexibly selected according to personal circumstances. The important thing is to maintain regular and continuous medication. Patients should follow the doctor's instructions when taking medication and undergo regular check-ups to ensure treatment effectiveness and safety.

Reference materials:https://www.drugs.com/